by In2Pharma | Dec 12, 2022 | News
Belgium Please note that the FAMHP added a Q&A to their FAQ of Unmet Medical Need. It concerns the provision of medicinal products for free (or at a reduced cost) to patients when a Medical Need Program is not in place or has ended. Is it possible to give a...
by In2Pharma | Jul 5, 2022 | News
Belgium On 4th of July 2022, the FAMHP launches the Medicinal Product Management database, a new internal database for medicinal products. Due to the launch of the new database, existing databases will temporarily not be updated. As from 22nd June data will be...
by In2Pharma | Jun 22, 2022 | News
Belgium The Vigilance Division of the FAMHP requests marketing authorisation holders to send the approved version of the risk management plan for medicinal products for human use with a national marketing authorisation.In order to have a better overview of the...
by In2Pharma | Jun 21, 2022 | News
Belgium We remind you that the honorary indexation of the Pharmacy distribution price in Belgium has an impact on the prices and this difference must be URGENTLY communicated to the Ministry of Social Security. Indeed, the Luxembourgish law imposes that the price of...
by In2Pharma | Jun 21, 2022 | News
Belgium In the context of the transparency policy conducted by the FAMHP, the FAMHP announced thematic audits starting from March 2022 at wholesalers in medicines for human use. These inspections will be unannounced. The inspections will focus on the obligations of...
